Literature DB >> 32171728

Can insulin secreting pancreatic β-cells provide novel insights into the metabolic regulation of the DNA damage response?

Bryndon J Oleson1, John A Corbett2.   

Abstract

Insulin, produced by pancreatic β-cells, is responsible for the control of whole-body glucose metabolism. Insulin is secreted by pancreatic β-cells in a tightly regulated process that is controlled by the serum level of glucose, glucose sensing and glucose oxidative metabolism. The regulation of intermediary metabolism in β-cells is unique as these cells oxidize glucose to CO2 on substrate supply while mitochondrial oxidative metabolism occurs on demand, for the production of intermediates or energy production, in most cell types. This review discusses recent findings that the regulation of intermediary metabolism by nitric oxide attenuates the DNA damage response (DDR) and DNA damage-dependent apoptosis in a β-cell selective manner. Specific focus is placed on the mechanisms by which iNOS derived nitric oxide (low micromolar levels) regulates DDR activation via the inhibition of intermediary metabolism. The physiological significance of the association of metabolism, nitric oxide and DDR signaling for cancer biology and diabetes is discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta cell; DNA damage response; Islet; Metabolism; Mitochondria; Nitric oxide; Oxidation

Mesh:

Substances:

Year:  2020        PMID: 32171728      PMCID: PMC7263971          DOI: 10.1016/j.bcp.2020.113907

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  104 in total

1.  Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells.

Authors:  F Schuit; A De Vos; S Farfari; K Moens; D Pipeleers; T Brun; M Prentki
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide.

Authors:  Katherine J Hughes; Gordon P Meares; Polly A Hansen; John A Corbett
Journal:  J Biol Chem       Date:  2011-01-01       Impact factor: 5.157

3.  Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism.

Authors:  C Southern; D Schulster; I C Green
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

4.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

Review 5.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage.

Authors:  Anna L Scarim; Sheri Y Nishimoto; Sarah M Weber; John A Corbett
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

7.  Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.

Authors:  J A Corbett; J L Wang; J H Hughes; B A Wolf; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

Review 8.  The Warburg Effect: How Does it Benefit Cancer Cells?

Authors:  Maria V Liberti; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2016-01-05       Impact factor: 13.807

9.  Repair of nitric oxide-damaged DNA in beta-cells requires JNK-dependent GADD45alpha expression.

Authors:  Katherine J Hughes; Gordon P Meares; Kari T Chambers; John A Corbett
Journal:  J Biol Chem       Date:  2009-08-02       Impact factor: 5.157

Review 10.  Pancreatic β-cell identity, glucose sensing and the control of insulin secretion.

Authors:  Guy A Rutter; Timothy J Pullen; David J Hodson; Aida Martinez-Sanchez
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

View more
  1 in total

1.  Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associated.

Authors:  Shiva Reddy; Lars Krogvold; Charlton Martin; Kevin Xueying Sun; Owen Martin; Aamenah Al-Ani; Knut Dahl-Jørgensen
Journal:  Cell Tissue Res       Date:  2021-01-11       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.